How can local certification of small and mid-sized enterprises (SMEs) help to alleviate anti-corruption due diligence for SMEs as well as multinational corporations (MNC) seeking to work with them?

A new Working Paper by the Basel Institute's Collective Action team attempts to answer that question, which is of real practical relevance to businesses around the world. The paper offers six clear recommendations to practitioners based on discussions and analysis of current local certification initiatives in different countries and sectors.

An illuminating new report by our OECD partners on Responsible Business Conduct and Anti-Corruption Compliance in Southeast Asia illustrates three points we have long emphasised at the Basel Institute.

This case study and Q&A looks at a recent UK Business Integrity Initiative-funded project in Ghana to create and implement 10 service delivery charters for government licensing and approval authorities through a Collective Action approach. The project was carried out by the Ghana Integrity Initiative, which is the local chapter of Transparency International, in collaboration with the Private Enterprise Federation.

In this short video, Gabriel Cifuentes, former Secretary of Transparency in the Office of the President in Colombia, talks about his experience in implementing the second High Level Reporting Mechanism (HLRM) to ensure a clean procurement process for the construction of the Bogotá Metro.

How effectively does the Business 20 (B20) process channel recommendations on anti-corruption from the business community up to the Group of Twenty (G20) leaders? Are there ways to increase the uptake of B20 recommendations by the G20 Anti-Corruption Working Group (ACWG) and in the final Communiqué at the G20 Summit?

The Basel Institute’s Collective Action team has facilitated the co-development of a set of indicators that health care companies may wish to consider when reporting on the effectiveness of their anti-corruption efforts to external stakeholders.

The guidance note containing the indicators was developed over seven months by a group of health care companies under an innovative project of Norges Bank Investment Management.